Injective (INJ) is an interoperable Layer 1 blockchain for DeFi applications. At the time of writing (November 6, 2026) the price is $8.43. This page gives bear, base and bull scenarios for 2026, 2027 and 2030.
Injective price today
Injective trades at $8.43, up 13.0% over the past 30 days, 91.2% over 90 days and 33.2% over the last year. The token sits near the top of its 52-week range, with a high of $8.94 and a low of $2.75, indicating that it has recovered most of the loss since its all-time high of $52.62 in March 2024. It is currently above the 200-day moving average of $5.64, which many analysts view as a sign of short-term strength. The market cap stands at $843 million, ranking it 81st by size, and the circulating supply is 100 million tokens with no fixed maximum supply.
| Metric | Value |
|---|---|
| Price | $8.43 |
| 30 day change | +13.0% |
| 90 day change | +91.2% |
| 1 year change | +33.2% |
| 52 week range | $2.75 to $8.94 |
| All time high | $52.62 (March 14, 2024), -84.0% from today |
| 200 day average | $5.64 |
| Annual volatility (1 year) | 103% |
| Market cap | $843 million (rank #81) |
Market data from CoinGecko at the time of writing (November 6, 2026).
Injective price prediction at a glance
Below are the statistical scenarios for the end of each target year. The numbers are taken directly from Injective’s own price volatility and are presented without any directional bias.
| Period | Bear case | Base case | Bull case |
|---|---|---|---|
| End of 2026 | $6.04 | $7.63 to $9.31 | $11.80 |
| End of 2027 | $3.30 | $6.40 to $11.00 | $21.00 |
| End of 2030 | $1.40 | $5.00 to $14.00 | $49.00 |
Statistical scenarios based on Injective's one year volatility (103% a year). Not financial advice.
The bear case represents the low end of the range, the base case the middle range, and the bull case the high end. Readers can use these three points to gauge the breadth of possible outcomes and to understand how different market conditions might affect the token.
Injective price prediction 2026
For the end of 2026 the bear scenario is $6.04, the base range spans $7.63 to $9.31 and the bull scenario reaches $11.80. A bull outcome would likely require continued strong DeFi adoption, successful cross-chain integrations, and a favorable Bitcoin market that keeps overall crypto sentiment positive. If developers launch new decentralized exchanges or prediction markets on Injective, transaction volume could rise, supporting higher token demand.
A bear outcome could arise if Bitcoin trends lower, liquidity tightens, or regulatory pressure slows ecosystem growth. A significant drop in broader crypto market liquidity would reduce trading activity on Injective’s DEXs, putting downward pressure on the token price. The current volatility of 103% suggests that price swings of this magnitude are within historical norms.
Injective price prediction 2027
Looking ahead to the end of 2027, the bear scenario is $3.30, the base range $6.40 to $11.00 and the bull scenario $21.00. The bull case would depend on major network upgrades, expanded partnerships with other blockchains, and a broader crypto market rally that lifts most altcoins. For example, if the project’s cross-chain bridge gains traction with Ethereum and Solana users, the resulting increase in on-chain activity could drive token demand upward.
The bear case might materialize if token unlocks increase supply pressure, or if macro-economic conditions dampen crypto demand. A slowdown in global liquidity or higher interest rates could reduce investors’ appetite for riskier assets like INJ, pushing the price toward the lower end of the range.
Injective price prediction 2030
Long-range scenarios for the end of 2030 show a bear price of $1.40, a base range of $5.00 to $14.00 and a bull price of $49.00. These numbers are very uncertain and reflect statistical volatility rather than a forecast. Over a longer horizon, many variables can change, including the evolution of DeFi, the emergence of new Layer-1 competitors, and shifts in regulatory frameworks.
Long-term outcomes will be shaped by overall blockchain adoption, competition from other smart-contract platforms, and the health of the broader crypto market. If DeFi continues to grow and Injective secures a niche as a cross-chain hub, the token could stay near the higher end of the base range or even reach the bull scenario. Conversely, if the market contracts or newer technologies eclipse its capabilities, the price could fall toward the bear level.
What could move the Injective price
- Overall market sentiment and Bitcoin price movements, which often set the tone for altcoin performance.
- Interest rates, liquidity conditions and macro-economic trends that affect investors’ risk appetite.
- Adoption of the Injective protocol, including new dApps, decentralized exchanges, and cross-chain bridges.
- Token supply dynamics such as circulating supply growth or future unlock events that could increase sell pressure.
- Regulatory developments affecting DeFi, cross-chain activity, and token classification.
- Competitive pressure from other smart-contract platforms that may attract developers away from Injective.
How we built these scenarios
The ranges come from Injective's own price swings (annual volatility 103%) over the past year, projected to each target date. We took the historical high-low band for each future period and placed the bear, base low, base high and bull points within that band. No assumption was made that the price will move up or down; the scenarios are purely statistical and are not investment advice.
For more crypto price predictions see more crypto price predictions and for beginner guidance check beginner crypto guides. The official website is https://injective.com. You may also find related analysis in our recent Crypto Market Today (Nov 6) article.
Frequently asked questions
Can Injective reach $21.00?
What is the Injective price prediction for 2030?
Is Injective a good investment?
What factors could cause Injective to drop to $3.30?
Sources
This article is for educational purposes only and is not financial advice. Crypto assets are volatile, so always do your own research. Read our editorial policy.
